0001213900-26-070389 | 6-K | XBRL Viewer | Superx AI Technology LTD

Document And Entity Information	6 Months Ended
Dec. 31, 2025
Document Information Line Items
Entity Central Index Key	0001897087
Document Type	6-K
Entity File Number	001-42013
Entity Registrant Name	SuperX AI Technology Limited
Amendment Flag	false
Document Period End Date	Dec. 31, 2025
Document Fiscal Year Focus	2026
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--06-30

Unaudited Condensed Consolidated Balance Sheets - USD ($)

Dec. 31, 2025

Jun. 30, 2025

Current assets

Cash and cash equivalents

$ 188,054,737

$ 17,206,993

Accounts receivable, net

615,687

185,054

Contract assets

643,408

34,084

Contract costs

20,431

Inventories

14,576,567

Income tax receivable

3,614

Loans receivable, net, current

22,640,182

20,397,475

Prepayments, deposits and other receivables, current

4,343,913

1,085,462

Total current assets

230,956,337

39,029,217

Non-current assets

Property and equipment, net

3,615,573

246,371

Intangible assets

2,889,035

Operating lease right-of-use assets, net

2,378,168

1,001,610

Investments in equity securities

567,455

966,829

Investments in equity method investees

1,883,467

Loans receivable, net, non-current

1,078,000

9,740,817

Prepayments and deposits, non-current

1,866,140

1,022,554

Deferred tax assets, net

42,550

43,749

Total assets

245,298,704

52,051,147

Current liabilities

Accounts payable

883,706

416,105

Accrued expenses and other payables

1,677,286

300,611

Amounts due to related parties

1,111,920

173,885

Contract liabilities

588,816

49,989

Contingent consideration payable

29,189,460

29,633,064

Bank and other borrowings, current

285,607

453,070

Income tax payable

64,180

Operating lease liabilities, current

1,253,632

739,105

Total current liabilities

35,075,434

31,837,248

Non-current liabilities

Bank and other borrowings, non-current

114,781

122,891

Operating lease liabilities, non-current

1,029,044

262,612

Total liabilities

36,270,035

32,222,751

Mezzanine equity

Redeemable noncontrolling interests

2,512,190

Shareholders’ equity

Ordinary shares, no par value, unlimited number of ordinary shares authorized, 43,216,535 and 22,169,854 ordinary shares issued and outstanding as of December 31, 2025 and June 30, 2025, respectively*

^[1]

244,920,720

33,104,858

Additional paid-in capital

59,608,946

8,973,101

Accumulated other comprehensive income

60,774

67,114

Accumulated deficit

(98,073,961)

(22,316,677)

Total equity

206,516,479

19,828,396

Total liabilities, mezzanine equity and equity

245,298,704

52,051,147

Related Party

Current assets

Amounts due from related parties

70,903

70,674

Rental deposits – related parties, current

21,783

Prepayments – related parties

7,326

7,261

Non-current assets

Rental deposits – related parties, non-current

21,979

Current liabilities

Operating lease liabilities - related parties, current

85,007

7,239

Non-current liabilities

Operating lease liabilities - related parties, non-current

$ 50,776

[1]	Shares and per share data are presented on a retroactive basis to reflect the nominal share issuance and share split.

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)

6 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Revenue

$ 2,832,267

$ 737,981

$ 1,662,285

Cost of revenue

2,437,770

691,406

1,255,208

Gross profit

394,497

46,575

407,077

Operating expenses

Selling and marketing expenses

42,975

3,092

3,439

General and administrative expenses

49,527,466

6,318,303

717,631

Total operating expenses

49,570,441

6,321,395

721,070

Loss from operations

(49,175,944)

(6,274,820)

(313,993)

Other income (expense)

Interest income (expense), net

1,173,858

115,897

(5,183)

Other income

61,182

Realized gains from disposal of investments in equity securities

1,131,921

Unrealized gains from fair value changes of investments in equity securities

76,051

Losses from fair value changes of contingent consideration payable

(29,324,471)

Loss on disposal of a subsidiary

(6,688)

Share of results of equity method investees

(60,015)

Gain on termination of lease

15,392

(Loss) gain on disposal of property and equipment

(14,254)

22,465

Total other (expense) income, net

(26,947,024)

138,362

86,889

Loss before provision for income taxes

(76,122,968)

(6,136,458)

(227,104)

Income tax benefit (expense)

(1,589)

26,850

(3,288)

Net loss

(76,124,557)

(6,109,608)

(230,392)

Net loss attributable to noncontrolling interests

367,273

Net loss attributable to SuperX AI Technology Limited

(75,757,284)

(6,109,608)

(230,392)

Accretion of redeemable noncontrolling interests

Net loss attributable to ordinary shareholders

(75,757,284)

(6,109,608)

(230,392)

Net loss

(76,124,557)

(6,109,608)

(230,392)

Other comprehensive income

Foreign currency translation adjustments

(9,229)

67,760

2,502

Total comprehensive loss

(76,133,786)

(6,041,848)

(227,890)

Total comprehensive loss attributable to noncontrolling interests

370,162

Total comprehensive loss attributable to ordinary shareholders

$ (75,763,624)

$ (6,041,848)

$ (227,890)

Loss per share

Basic (in Dollars per share)

^[1]

$ (2.43)

$ (0.47)

$ (0.022)

Diluted (in Dollars per share)

^[1]

$ (2.43)

$ (0.47)

$ (0.022)

Weighted average shares outstanding

Basic (in Shares)

^[1]

31,179,382

12,993,984

10,714,286

Diluted (in Shares)

^[1]

31,179,382

12,993,984

10,714,286

Related Party

Other income (expense)

Other income – related party

$ 92,072

[1]	Shares and per share data are presented on a retroactive basis to reflect the nominal share issuance and share split.

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net loss	$ (76,124,557)	$ (6,109,608)	$ (230,392)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation of property and equipment	130,455	39,482	5,060
Amortization of operating lease right-of-use assets and interest of lease liabilities	840,520	290,277	44,544
Provision for (reversal of) allowance for current expected credit losses	170	4,551	(4,188)
Realized gains from disposal of investments in equity securities	(1,131,921)
Unrealized gains from fair value changes of investments in equity securities	(76,051)
Losses from fair value changes of contingent consideration payable	29,324,471
(Loss) gain on disposal of property and equipment	14,254	(22,465)
Loss on disposal of a subsidiary	6,688
Share of results of equity method investees	60,015
Gain on termination of lease	(15,392)
Share-based compensation	31,426,378	3,111,726
Dividend income	(13,088)
Deferred tax expense (benefit)	1,589	(26,850)	737
Changes in operating assets and liabilities:
Accounts receivable	(430,258)	172,491	386,829
Contract assets	(609,324)	213,942	(220,120)
Contract costs	20,431	(10,620)	(16,447)
Prepayments, deposits and other receivables	(3,194,586)	(743,413)	(7,245)
Inventories	(14,576,567)
Accounts payable	467,601	29,135	(120,952)
Contract liabilities	538,827	247,305	236,466
Income taxes payable	(67,794)		2,551
Operating lease liabilities, related parties	(43,846)	(43,902)	(43,734)
Operating lease liabilities	(580,623)	(240,930)
Accrued expenses and other payables	(2,789,776)	192,265	30,699
Net cash (used in) provided by operating activities	(36,822,384)	(2,896,614)	63,808
Cash flows from investing activities:
Purchases of property and equipment	(3,511,920)	(258,860)	(6,535)
Prepayments for the acquisition of property and equipment and right-of-use assets	(913,046)
Deposits paid for investments		(443,646)
Decrease (increase) in loans receivable	6,233,423	(179,951)
Acquisition of a subsidiary	4,059,629
Disposal of a subsidiary	480,000
Acquisition of equity method investees	(1,161,142)
Investments in equity securities	(1,133,536)	(478,768)
Proceeds from disposal of investments in equity securities	2,265,457
Proceeds from disposal of property and equipment		22,465
Dividend income received	13,088
Net cash provided by (used in) investing activities	6,331,953	(1,338,760)	(6,535)
Cash flows from financing activities:
Payments of offering costs related to IPO			(108,470)
Proceeds from bank and other borrowings		128,370
Repayments of bank and other borrowings	(148,910)	(85,628)	(75,115)
Proceeds from the issuance of ordinary shares under private placements	187,741,800
Proceeds from the exercise of warrants	12,407,121
Proceeds from the exercise of share options	1,375,000
Repayments to related parties			(60,741)
Advances from related parties	751	113,070
Net cash provided by (used in) financing activities	201,375,762	155,812	(244,326)
Effect of exchange rate changes on cash	(37,587)	67,621	1,190
Net increase (decrease) in cash	170,847,744	(4,011,941)	(185,863)
Cash, beginning of period	17,206,993	7,244,941	558,386
Cash, end of period	188,054,737	3,233,000	372,523
Supplemental disclosure information:
Cash paid for interest	13,607	4,517	6,464
Supplemental non-cash in investing and financing activities:
Operating lease right-of-use assets, obtained in exchange for operating lease obligations, related parties	170,021		168,500
Operating lease right-of-use assets, obtained in exchange for operating lease obligations	$ 2,296,396	$ 976,769

Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity - USD ($)

Ordinary Shares

Additional Paid-in Capital

Accumulated Other Comprehensive (Loss) Income

Accumulated Deficit

Total

Beginning balance at Jun. 30, 2023

$ 1,000

$ 1,339,286

$ (329)

$ (247,290)

$ 1,092,667

Beginning balance (in Shares) at Jun. 30, 2023

^[1]

10,714,286

Net loss for the period

(230,392)

Foreign currency translation adjustments

2,502

Ending balance at Dec. 31, 2023

$ 1,000

1,339,286

2,173

(477,682)

864,777

Ending balance (in Shares) at Dec. 31, 2023

^[1]

10,714,286

Beginning balance at Jun. 30, 2024

$ 6,710,390

1,339,286

17,529

(1,102,217)

6,964,988

Beginning balance (in Shares) at Jun. 30, 2024

^[1]

12,977,354

Net loss for the period

(6,109,608)

Issuance of ordinary shares under 2024 equity incentive plan and 2025 equity incentive plan

$ 225,000

225,000

Issuance of ordinary shares under 2024 equity incentive plan and 2025 equity incentive plan (in Shares)

^[1]

50,000

Share-based compensation

2,887,926

Foreign currency translation adjustments

67,760

Ending balance at Dec. 31, 2024

$ 6,935,390

4,227,212

85,289

(7,211,825)

4,036,066

Ending balance (in Shares) at Dec. 31, 2024

^[1]

13,027,354

Beginning balance at Jun. 30, 2025

$ 33,104,858

8,973,101

67,114

(22,316,677)

19,828,396

Beginning balance (in Shares) at Jun. 30, 2025

^[1]

22,169,854

Net loss for the period

(75,757,284)

Issuance of ordinary shares under 2024 equity incentive plan and 2025 equity incentive plan

$ 2,997,861

2,997,861

Issuance of ordinary shares under 2024 equity incentive plan and 2025 equity incentive plan (in Shares)

^[1]

139,308

Share-based compensation

28,161,850

Issuance of ordinary shares under private placements

$ 157,582,617

157,582,617

Issuance of ordinary shares under private placements (in Shares)

^[1]

16,600,000

Issuance of warrants under private placements

30,159,183

Exercise of warrants

$ 19,072,632

(6,665,511)

12,407,121

Exercise of warrants (in Shares)

^[1]

3,009,998

Exercise of share options

$ 2,394,677

(1,019,677)

1,375,000

Exercise of share options (in Shares)

^[1]

297,000

Issuance of ordinary shares upon settlement of contingent consideration payable

$ 29,768,075

29,768,075

Issuance of ordinary shares upon settlement of contingent consideration payable (in Shares)

^[1]

1,000,375

Foreign currency translation adjustments

(6,340)

Ending balance at Dec. 31, 2025

$ 244,920,720

$ 59,608,946

$ 60,774

$ (98,073,961)

$ 206,516,479

Ending balance (in Shares) at Dec. 31, 2025

^[1]

43,216,535

[1]	Shares and per share data are presented on a retroactive basis to reflect the nominal share issuance and share split.

Print Document
Reports Document And Entity Information Statements Unaudited Condensed Consolidated Balance Sheets Unaudited Condensed Consolidated Balance Sheets (Parentheticals) Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity Unaudited Condensed Consolidated Statements of Cash Flows All Reports